-
B287053-5mgBI605906 is a novel IKKβ inhibitor with an IC50 value of 380 nM when assayed at 0.1 mM ATP.BI605906 is an inhibitor of IKKβ with improved selectivity. BI605906 inhibits IKKβ in vitro with an IC50 value of 380 nM when assayed at 0.1 mM ATP. The only
-
B104241-10gPotent, noncompetitive P2X 7 antagonist
-
B104241-250gPotent, noncompetitive P2X 7 antagonist
-
B104241-50gPotent, noncompetitive P2X 7 antagonist
-
B104241-5gPotent, noncompetitive P2X 7 antagonist
-
B288192-100mgBW B70C has been used as a 5-lipoxygenase inhibitor to study its effects on eryptosis in erythrocytes.
-
B288192-10mgBW B70C has been used as a 5-lipoxygenase inhibitor to study its effects on eryptosis in erythrocytes.
-
B288192-25mgBW B70C has been used as a 5-lipoxygenase inhibitor to study its effects on eryptosis in erythrocytes.
-
B288192-50mgBW B70C has been used as a 5-lipoxygenase inhibitor to study its effects on eryptosis in erythrocytes.
-
B288192-5mgBW B70C has been used as a 5-lipoxygenase inhibitor to study its effects on eryptosis in erythrocytes.
-
C287028-10mgSelective microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor
-
C287028-50mgSelective microsomal prostaglandin E synthase 1 (mPGES-1) inhibitor